1、1 1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in re
2、liance upon the whole or any part of the contents of this announcement.Chaoju Eye Care Holdings Limited朝聚眼科醫療控股有限公司(Incorporated in the Cayman Islands with limited liability)(Stock Code:2219)ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED DECEMBER 31,2025FINANCIAL AND OPERATIONAL HIGHLIGHTSRevenue of
3、the Group decreased by 3.2%to RMB1,360.4 million for the year ended December 31,2025 from RMB1,405.5 million for the year ended December 31,2024.Profit before tax of the Group decreased by 2.5%to RMB256.1 million for the year ended December 31,2025 from RMB262.7 million for the year ended December 3
4、1,2024.Pre-tax profit margin increased to 18.8%for the year ended December 31,2025 from 18.7%for the year ended December 31,2024.Net profit of the Group decreased by 4.7%to RMB177.4 million for the year ended December 31,2025 from RMB186.2 million for the year ended December 31,2024.Net profit margi
5、n decreased to 13.0%for the year ended December 31,2025 from 13.2%for the year ended December 31,2024.Non-IFRS adjusted net profit(Note)of the Group decreased by 7.3%to RMB187.9 million for the year ended December 31,2025 from RMB202.7 million for the year ended December 31,2024.Non-IFRS adjusted ne
6、t profit margin decreased to 13.8%for the year ended December 31,2025 from 14.4%for the year ended December 31,2024.Basic earnings per Share of the Group decreased by 6.5%to RMB0.26 for the year ended December 31,2025 from RMB0.28 for the year ended December 31,2024.2 2 As at December 31,2025,the nu